CD274 and neoplasm: The PD-1/PD-L1 signaling pathway has been shown to be important for tumor immunosuppression, inhibiting the activation of T lymphocytes and enhancing the immune tolerance of tumor cells, exhibiting an important regulatory role in the tumor immune microenvironment.